Investigation into Tandem Diabetes Care, Inc.
Recently, the Rosen Law Firm, which focuses on the rights of investors, has initiated an exploration into the potential securities claims concerning Tandem Diabetes Care, Inc. (NASDAQ: TNDM). This inquiry arises from claims that the company may have provided materially misleading information regarding its business practices.
Potential Investor Compensation
Investors who have purchased Tandem Diabetes Care securities may be eligible for compensation without incurring costs upfront, thanks to a contingency fee structure. The firm is working diligently on a class action that aims to recover losses sustained by these investors.
Details of the Allegations
On a crucial date, the company released a statement addressing a voluntary medical device correction for select t:slim X2 insulin pumps. This disclosure indicated that there might be a speaker-related issue potentially risking the discontinuation of insulin delivery. Following this news, Tandem Diabetes' stock price saw a drastic drop of nearly 20%.
Choosing the Right Legal Representation
When navigating complex securities issues, selecting legal counsel with proven success is vital. Many firms may not have the necessary resources or experience with securities class actions. The Rosen Law Firm has demonstrated significant expertise in this area, having achieved notable settlements in previous cases and gaining peer recognition as a leading firm in securities litigation.
About Rosen Law Firm
The Rosen Law Firm has represented investors internationally and has a dedicated focus on securities class actions and shareholder derivative litigation. The firm proudly holds the record for the largest settlement for a securities class action involving a Chinese company and has been ranked consistently among the top firms for recoveries in this sector.
Contact Information
For those affected or who need more information, the contact details for the Rosen Law Firm include:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll-Free: (866) 767-3653
Fax: (212) 202-3827
Email: [protected email]
Frequently Asked Questions
What is the current investigation about?
The investigation focuses on potential misleading information provided by Tandem Diabetes Care that may have impacted investors.
Who can join the proposed class action?
Any investor who purchased Tandem Diabetes Care securities during the relevant period may be eligible to join the class action.
What are contingency fee arrangements?
Contingency fee arrangements allow clients to pursue legal claims without upfront costs, with fees only collected if a settlement or judgment is successful.
How did the stock price react to recent news?
Following the announcement regarding the insulin pumps, Tandem Diabetes' stock dropped by nearly 20%, reflecting investor concern.
Why choose the Rosen Law Firm?
The Rosen Law Firm is known for its substantial recovery record and expertise in securities class action cases, making it a strong choice for affected investors.